Pfizer Asks FDA to Authorize Covid-19 Booster for 5- to 11-Year-Olds

April 27, 2022 by

Pfizer Inc. and partner BioNTech SE said earlier this month that a third shot safely generated a strong immune response in the youngsters.

PAID